Cart summary

You have no items in your shopping cart.

Lintuzumab Biosimilar(Anti-Siglec-3 / CD33 Reference Antibody)

Lintuzumab Biosimilar(Anti-Siglec-3 / CD33 Reference Antibody)

Catalog Number: orb2703720

DispatchUsually dispatched within 5-10 working days
$ 3,370.00
Catalog Numberorb2703720
CategoryAntibodies
DescriptionLintuzumab (HUM-195) is an anti-CD33 humanized monoclonal antibody. Lintuzumab reduces the production of TNFα-induced pro-inflammatory cytokines and chemokines by AML cells. Lintuzumab promotes tumor cell killing through antibody-dependent cellular cytotoxicity (ADCC) and phagocytosis (ADCP) activities against MDR? and MDR+ AML cell lines and primary AML patient samples. Lintuzumab enhances survival and reduces tumor burden in mice.
TargetLintuzumab Biosimilar(Anti-Siglec-3 / CD33 Reference Antibody)
ClonalityMonoclonal
ConjugationUnconjugated
Antibody TypePrimary Antibody
CAS Number[166089-32-3]
StorageMaintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
NoteFor research use only